A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines
Open Access
- 14 October 2013
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 4 (12) , 2271-2287
Abstract
LINE-1 elements make up the most abundant retrotransposon family in the human genome. Full-length LINE-1 elements encode a reverse transcriptase (RT) activity required for their own retrotranpsosition as well as that of non-autonomous Alu elements. LINE-1 are poorly expressed in normal cells and abundantly in cancer cells. Decreasing RT activity in cancer cells, by either LINE-1-specific RNA interference, or by RT inhibitory drugs, was previously found to reduce proliferation and promote differentiation and to antagonize tumor growth in animal models. Here we have investigated how RT exerts these global regulatory functions.Keywords
This publication has 68 references indexed in Scilit:
- Landscape of transcription in human cellsNature, 2012
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- miRNAs in human cancerThe Journal of Pathology, 2010
- All y’all need to know ‘bout retroelements in cancerSeminars in Cancer Biology, 2010
- MicroRNA Function Is Globally Suppressed in Mouse Oocytes and Early EmbryosCurrent Biology, 2010
- MicroRNA expression profiling of human metastatic cancers identifies cancer gene targetsThe Journal of Pathology, 2009
- Epigenetics: heterochromatin meets RNAiCell Research, 2009
- MicroRNA expression profiles classify human cancersNature, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Initial sequencing and analysis of the human genomeNature, 2001